Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea.

Size: px
Start display at page:

Download "Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea."

Transcription

1 Antacids Hawler medical university Collage of pharmacy/ fourth year /pharmacy practice Sham A. Talat Shareef (B.Sc. Msc. clinical pharmacy) Head of Department Of Clinical Pharmacy in DOH

2 Objectives Brand name Generic name Primary indication, drug classes Dosage forms Patient counseling information Important side effects and contraindications

3

4 Dyspepsia Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea. It can occur with gastric and duodenal ulceration and, gastric cancer, but most commonly it is of uncertain origin.

5 Referral cases Urgent endoscopic investigation is required if dyspepsia is accompanied by alarm features (e.g. bleeding, dysphagia, recurrent vomiting, or weight loss). Urgent investigation should also be considered for patients over 55 years with unexplained, recent-onset dyspepsia that has not responded to treatment.

6 Non pharmacological treatment Patients with dyspepsia should be advised about lifestyle changes (avoidance of excess alcohol and of aggravating foods such as fats). other measures include weight reduction, smoking cessation, and raising the head of the bed. Some medications may cause dyspepsia these should be stopped, if possible.

7 Antacids Antacids (usually containing aluminium or magnesiumm compounds) can often relieve symptoms in ulcer dyspepsia in non-erosive gastro-oesophageal reflux disease functional (non-ulcer) dyspepsia

8 Dispensing informations Antacids are best given when symptoms occur or are expected, usually between meals and at bedtime, although additional doses may be required.

9 Which antacid dosage form are more effective? Liquid preparations are more effective than tablet preparations

10 What does most antacids contain? Aluminium- and magnesium-containing antacids (e.g. aluminium hydroxide, and magnesium carbonate, hydroxide and magnesium trisilicate, being relatively insoluble in water, are long-acting if retained in the stomach. They are suitable for most antacid purposes. Magnesium-containing antacids tend to be laxative whereas aluminium-containing antacids may be constipating; antacids containing both magnesium and aluminium may reduce these colonic side-effects.

11 Which antacids No longer recommended to dispense?why Sodium bicarbonate: should no longer be prescribed alone for the relief of dyspepsia but it is present as an ingredient in many indigestion remedies. However, it retains a place in the management of urinary-tract disorders and acidosis. Bismuth-containing antacids (unless chelates): are not recommended because absorbed bismuth can be neurotoxic, causing encephalopathy; they tend to be constipating. Calcium-containing antacids: can induce rebound acid secretion: with modest doses the clinical significance is doubtful, but prolonged high doses also cause hypercalcaemia and alkalosis.

12 Other important component may be added to the antacid Simeticone Simeticone (activated dimeticone) is added to an antacid as an antifoaming agent to relieve flatulence. These preparations may be useful for the relief of hiccup in palliative care. Alginates Alginates taken in combination with an antacid increases the viscosity of stomach contents and can protect the oesophageal mucosa from acid reflux. Some alginate containing preparations form a viscous gel ( raft ) that floats on the surface of the stomach contents, thereby reducing symptoms of reflux.

13 Co-magaldrox ( aluminium hydroxide, magnesium hydroxide) Trade name : MUCOGEL MAALOX Indication :Dyspepsia MEDICINAL FORMS: Oral suspension, chewable tablets DISPENSING INFORMATION: are low in sodium. Maalox pulse: in addition cotaines semithecone (Simeticone (activated dimeticone) is an antifoaming agent.

14 Gaviscon

15 Difference in contents Gaviscon original contains Sodium Alginate, calcium carbonate and sodium bicarbonate. Gaviscon Advance contains Sodium Alginate and potassium bicarbonate. Gaviscon double action contains Sodium alginate, calcium carbonate, sodium bicarbonate Gaviscon Advance contains double the amount of Sodium Alginate than the Gaviscon original.

16 Difference in packaging and availability Gaviscon Original: is available in the form of chewable tablets, liquid and liquid sachets. Gaviscon Advance: is available in the form of tablets and liquids. Gaviscon double action: available in the form of chewable tablets, liquid and liquid sachets.

17 Gaviscon Original Soothing heartburn relief. Gets to work instantly. Lasts up to 2x longer than antacids. Suitable for use in pregnancy.

18 Gaviscon double action Dual relief from heartburn and indigestion.

19 Gaviscon Advance Liquids Soothing relief from heartburn, indigestion & reflux cough. Extra strength formula.

20 Gaviscon Infant Contains Sodium alginate and magnesium alginate Helps to prevent gastric reflux and regurgitation. Oral powder suspension Suitable for children ages 1 to 2

21 ANTACIDS CONTAIN ALGINATES

22 RENNE What Rennie Soft Chews contains: Each tablet contains the active ingredient: calcium carbonate 800mg.

23 RENNE Adults & children over 12 years: 1-2 tablets to be sucked or chewed, as required, preferably 1 hour after meals and before bedtime. For heartburn an extra 2 tablets may be taken between these times. Do not take more than 10 tablets a day. Children under 12 years: Not recommended. Pregnancy and breast-feeding: Rennie Soft Chews can be used during pregnancy and breastfeeding if taken as instructed

24 WHAT ARE RENNIE AND WHAT ARE THEY USED FOR? Rennie Soft Chews are soft and chewy antacid tablets, with a smooth freshmint taste, which quickly and effectively relieve the discomfort of indigestion, heartburn, acid indigestion, dyspepsia, nervous indigestion, flatulence, upset stomach, indigestion during pregnancy and biliousness.

25 containdications If you have severe kidney disease. If you have high calcium in the urine or kidney stones. If you have high calcium or low phosphate levels in the blood.

26 SIDE EFFECTS Long term use of high doses can cause high blood levels of calcium, especially in people with kidney conditions. Symptoms of this may include nausea, vomiting, upset stomach, diarrhoea, tiredness, muscular weakness, headache, kidney problems and impaired sense of taste.

27

28

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D Gastro-oesophageal reflux disease and peptic ulcer disease Learning objectives:

More information

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA MANAGEMENT Dyspepsia refers to a spectrum of usually intermittent upper gastrointestinal symptoms, including epigastric pain and heartburn. For the majority

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets Read all of this leaflet carefully because it contains important

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 14 September 2011

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 14 September 2011 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 14 September 2011 GAVISCON PEPPERMINT, chewable tablet B/20 (CIP code: 367 909-6) GAVISCON, oral suspension 250 ml

More information

Antacid therapy: Antacids side effects:

Antacid therapy: Antacids side effects: Antacids Lec:5 When the general public ask why it takes antacids, the answer will include: 1.that uncomfortable feeling from overeating. 2. heart burn. 3. a growing hungry feeling between meals. Antacids

More information

Reflux of gastric contents, particularly acid, into the esophagus

Reflux of gastric contents, particularly acid, into the esophagus Heartburn Reflux of gastric contents, particularly acid, into the esophagus Patient assessment with GERD 1-signs and symptoms The hallmark of typical symptom of GERD is heartburn (restrosternal),acid regurgitation,

More information

BNF/BNFC Chapter 1 Gastro-intestinal System

BNF/BNFC Chapter 1 Gastro-intestinal System NF/NF hapter 1 Gastro-intestinal System irections for questions 1 to 10. ach of the questions or incomplete statements in this section is followed by five suggested answers. Select the best answer in each

More information

APOHEALTH Diarrhoea Relief PLUS

APOHEALTH Diarrhoea Relief PLUS APOHEALTH Diarrhoea Relief PLUS Chewable Tablets Contains the active ingredient Loperamide hydrochloride and Simethicone Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195

More information

Self-care information on indigestion

Self-care information on indigestion Self-care information on indigestion 2 What is indigestion? Indigestion (also known as dyspepsia) is a term which describes pain or discomfort in your chest or stomach. What causes indigestion? It is caused

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA o Patients of any age with ALARM signs should be referred through the 2-week referral system o Routine endoscopic investigation

More information

ANTACID LABELLING STANDARD

ANTACID LABELLING STANDARD ANTACID LABELLING STANDARD CATEGORY: DESCRIPTION: Antacid Single and multiple ingredient drugs, containing medicinal ingredients suitable for self-medication, which are intended to relieve symptoms such

More information

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet

More information

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) Routine endoscopic investigation of patients of any age, presenting with dyspepsia

More information

SUCRALFATE TABLETS, USP

SUCRALFATE TABLETS, USP 1234567890 10 210002 SUCRALFATE TABLETS, USP DESCRIPTION Sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex. It has the following structural formula:

More information

MOVICOL HALF PI December MOVICOL-Half. Powder for Solution (macrogol 3350) Potassium 5.4 mmol/l. Bicarbonate 17 mmol/l

MOVICOL HALF PI December MOVICOL-Half. Powder for Solution (macrogol 3350) Potassium 5.4 mmol/l. Bicarbonate 17 mmol/l MOVICOL -Half Powder for Solution (macrogol 3350) Product Name: Product Description: MOVICOL-Half Each sachet of MOVICOL-Half contains: Macrogol 3350 6.563 g Sodium chloride 175.4 mg Sodium bicarbonate

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lacrofarm Junior, powder for oral solution, sachet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of contains the following active

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Magnesium Trisilicate Mixture B.P. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Magnesium Trisilicate B.P. 250 mg/5 ml Light Magnesium

More information

MOVICOL Junior Powder for Solution (macrogol 3350)

MOVICOL Junior Powder for Solution (macrogol 3350) MOVICOL Junior Powder for Solution (macrogol 3350) Product Name: MOVICOL Junior Product Description: Each sachet of MOVICOL Junior contains: Macrogol 3350 Sodium chloride Sodium bicarbonate Potassium chloride

More information

2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution contains the following active ingredients:

2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution contains the following active ingredients: SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Macrovic Junior powder for oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution

More information

GI Pharmacology. Dr. Alia Shatanawi 5/4/2018

GI Pharmacology. Dr. Alia Shatanawi 5/4/2018 GI Pharmacology Dr. Alia Shatanawi 5/4/2018 Drugs Used in Gastrointestinal Diseases Drugs used in Peptic Ulcer Diseases. Drugs Stimulating Gastrointestinal Motility &Laxatives. Antidiarrheal Agents. Drugs

More information

SUCRALFATE TABLETS, USP

SUCRALFATE TABLETS, USP 1234567890 10 210002-01 SUCRALFATE TABLETS, USP DESCRIPTION Sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex. It has the following structural formula:

More information

PATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate

PATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate PATIENT INFORMATION LEAFLET Calcichew* 500 mg Chewable Tablets calcium carbonate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials. Name Gasec - 2 Gastrocaps Composition Gasec-20 Gastrocaps Each Gastrocaps contains: Omeprazole 20 mg (in the form of enteric-coated pellets) Properties, effects Proton Pump Inhibitor Omeprazole belongs

More information

Bisacodyl Laxative (Pharmacy Health)

Bisacodyl Laxative (Pharmacy Health) Bisacodyl Laxative (Pharmacy Health) Each Enteric Coated Tablet contains 5 mg Bisacodyl BP/Ph. Eur Gastro resistant Tablets What is in this leaflet This leaflet answers some common questions about Bisacodyl

More information

Evaluation of the buffering capacity of powdered cow s, goat s and soy milk and non-prescription antacids in the treatment of non-ulcer dyspepsia

Evaluation of the buffering capacity of powdered cow s, goat s and soy milk and non-prescription antacids in the treatment of non-ulcer dyspepsia Evaluation of the buffering capacity of powdered cow s, goat s and soy milk and non-prescription antacids in the treatment of non-ulcer dyspepsia D Lutchman, S Pillay, R Naidoo, N Shangase, R Nayak, A

More information

SUMMARY OF PRODUCT CHARACTERISTICS. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains the following active ingredients:

SUMMARY OF PRODUCT CHARACTERISTICS. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains the following active ingredients: SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lacrofarm, powder for oral solution, sachet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains the following active ingredients:

More information

Package leaflet: Information for the patient. Megalac Almasilate 1 g/10 ml suspension. Active substance: almasilate

Package leaflet: Information for the patient. Megalac Almasilate 1 g/10 ml suspension. Active substance: almasilate Package leaflet: Information for the patient Megalac Almasilate 1 g/10 ml suspension Active substance: almasilate Read all of this leaflet carefully before you start taking this medicine because it contains

More information

MOVICOL Junior Chocolate Flavour Powder for Solution (macrogol 3350)

MOVICOL Junior Chocolate Flavour Powder for Solution (macrogol 3350) MOVICOL Junior Chocolate Flavour Powder for Solution (macrogol 3350) Product Name: MOVICOL Junior Chocolate Flavour Product Description: Each sachet of MOVICOL Junior Chocolate contains: Macrogol 3350

More information

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Compound Macrogol 13.72 g powder for oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Compound Macrogol 13.72 g

More information

Heartburn, also referred to acid reflux, happens when stomach acid flows back (refluxes) into your esophagus.

Heartburn, also referred to acid reflux, happens when stomach acid flows back (refluxes) into your esophagus. WHILE almost everyone experiences mild heartburn from time to time and many individuals have some antacids or another medication on hand for its relief, talk to your doctor, if you have heartburn more

More information

PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW

PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Dyspepsia refers to a broad range of symptoms related

More information

PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg. Please read this leaflet carefully before taking LANCAP capsules.

PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg. Please read this leaflet carefully before taking LANCAP capsules. PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg Please read this leaflet carefully before taking LANCAP capsules. Keep this leaflet. You may need to read it again. If you have any further questions,

More information

COMMON MEDICINES USED IN CKD CHRONIC KIDNEY DISEASE

COMMON MEDICINES USED IN CKD CHRONIC KIDNEY DISEASE CHRONIC KIDNEY DISEASE 1 This information is intended to help you understand why you need to take your medicines. There are multiple medicines that are used to control the symptoms related to CKD. You

More information

CREON Capsules Pancreatic Extract Enteric-Coated Minimicrospheres

CREON Capsules Pancreatic Extract Enteric-Coated Minimicrospheres CREON Capsules Pancreatic Extract Enteric-Coated Minimicrospheres Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions about Creon 10,000, Creon 25,000

More information

Package Leaflet: Information for the Patient. FOSRENOL 750 mg oral powder. FOSRENOL 1000 mg oral powder. lanthanum

Package Leaflet: Information for the Patient. FOSRENOL 750 mg oral powder. FOSRENOL 1000 mg oral powder. lanthanum Package Leaflet: Information for the Patient FOSRENOL 750 mg oral powder FOSRENOL 1000 mg oral powder lanthanum Read all of this leaflet carefully before you start taking this medicine because it contains

More information

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000 Package leaflet: Information for the user 10 g powder for oral solution in sachet Macrogol 4000

More information

Package leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide

Package leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide Package leaflet: Information for the patient Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide This medicine is subject to additional monitoring. This will allow quick identification of

More information

Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease

Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease Information for patients The following pages offer you information on some of the medicines that you may need. It is

More information

PATIENT INFORMATION LEAFLET PEPLOC RANGE

PATIENT INFORMATION LEAFLET PEPLOC RANGE Scheduling Status: S4 Proprietary name, Strength and Pharmaceutical Form: Peploc 20 mg tablets Peploc 40 mg tablets Read all of this leaflet carefully before using PEPLOC 20 mg or 40 mg Keep this leaflet.

More information

DYSPEPSIA Dyspepsia indigestion during or after eating Full Heat, burning or pain Note: one of every four people

DYSPEPSIA Dyspepsia indigestion during or after eating Full Heat, burning or pain Note: one of every four people What Is Dyspepsia? Dyspepsia, also known as indigestion, can have multiple symptoms. Feelings of indigestion happen during or after eating. If you have indigestion you might feel: Full during a meal. Painful

More information

PRODUCT INFORMATION RESONIUM A. Na m

PRODUCT INFORMATION RESONIUM A. Na m PRODUCT INFORMATION RESONIUM A NAME OF THE MEDICINE Non-proprietary Name Sodium polystyrene sulfonate Chemical Structure CH - 2 CH SO 3 Na + n CAS Number 28210-41-5 [9003-59-2] CH 2 CH SO - 3 m DESCRIPTION

More information

HIATUS HERNIAS. Contents What is a Hiatus Hernia?... 3

HIATUS HERNIAS. Contents What is a Hiatus Hernia?... 3 Contents What is a Hiatus Hernia?........................ 3 What about exercise?............................ 6 YOUR GUIDE TO HIATUS HERNIAS An IPRS Guide to provide you with exercises and advice to ease

More information

ANATOMY PHYSIOLOGY LAB 2-1 HOW POWERFUL IS YOUR ANTACID?

ANATOMY PHYSIOLOGY LAB 2-1 HOW POWERFUL IS YOUR ANTACID? ANATOMY PHYSIOLOGY LAB 2-1 HOW POWERFUL IS YOUR ANTACID? Introduction: Explore the properties and uses of antacids. Watch an "antacid in action" as it neutralizes simulated stomach acid. Determine the

More information

MOVICOL Liquid Orange Flavour Concentrate for Oral Solution (macrogol 3350)

MOVICOL Liquid Orange Flavour Concentrate for Oral Solution (macrogol 3350) MOVICOL Liquid Orange Flavour Concentrate for Oral Solution (macrogol 3350) NAME OF THE MEDICINE: MOVICOL Liquid Orange Flavour, Concentrate for Oral Solution. DESCRIPTION: A clear colourless solution.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. ULCERBREX 10 mg mg gastro-resistant tablets Rabeprazole sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. ULCERBREX 10 mg mg gastro-resistant tablets Rabeprazole sodium PACKAGE LEAFLET: INFORMATION FOR THE USER ULCERBREX 10 mg mg gastro-resistant tablets Rabeprazole sodium Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Package Leaflet: Information for the Patient. FOSRENOL 750 mg chewable tablets. FOSRENOL 1000 mg chewable tablets. lanthanum

Package Leaflet: Information for the Patient. FOSRENOL 750 mg chewable tablets. FOSRENOL 1000 mg chewable tablets. lanthanum Package Leaflet: Information for the Patient FOSRENOL 250 mg chewable tablets FOSRENOL 500 mg chewable tablets FOSRENOL 750 mg chewable tablets FOSRENOL 1000 mg chewable tablets lanthanum Read all of this

More information

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13 BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM 1 BNF 1.1 ANTACIDS Mucogel and Peptac are effective antacids and are available over the counter Gaviscon / Gaviscon Advance are available over the counter First

More information

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT "Carbellon" Tablets. 2. Qualitative and Quantitative Composition Active Constituents: Activated Charcoal Ph.Eur. Magnesium Hydroxide Ph.Eur.

More information

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC. SCHEDULING STATUS: S4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNAFLOC 250 (tablets) DYNAFLOC 500 (tablets) DYNAFLOC 750 (tablets) Read this entire leaflet carefully before you start taking

More information

MOVICOL Lemon-Lime Flavour Powder for Solution (macrogol 3350)

MOVICOL Lemon-Lime Flavour Powder for Solution (macrogol 3350) MOVICOL Lemon-Lime Flavour Powder for Solution (macrogol 3350) Product Name: MOVICOL Lemon-Lime Flavour Product Description: Each sachet of MOVICOL Lemon-Lime contains: Macrogol 3350 Sodium chloride Sodium

More information

SUCRALFATE ISELPIN 1 g Tablet

SUCRALFATE ISELPIN 1 g Tablet 1.0 PHARMACOLOGIC CATEGORY CYTOPROTECTOR 2.0 DESCRIPTION SUCRALFATE ISELPIN 1 g Tablet Sucralfate is a white, amorphous powder which is soluble in strong acids and in alkalis but practically insoluble

More information

Difference between omeprazole and omeprazole delayed release

Difference between omeprazole and omeprazole delayed release Cari untuk: Cari Cari Difference between omeprazole and omeprazole delayed release 7-2-2018 Easy to read patient leaflet for Omeprazole Delayed-Release Capsules. Includes indications, proper use, special

More information

Package leaflet: Information for the user. Ulcerbrex 20 mg gastro-resistant tablets Rabeprazole sodium

Package leaflet: Information for the user. Ulcerbrex 20 mg gastro-resistant tablets Rabeprazole sodium Package leaflet: Information for the user Ulcerbrex 20 mg gastro-resistant tablets Rabeprazole sodium Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee Guidelines for the Management of Dyspepsia and GORD Document type: Version: 3.0 Author (name): Author (designation): Validated by Prescribing Dr. G. Lipscomb Date validated October 2015 Ratified by: Date

More information

James Paget University Hospitals. NHS Foundation Trust. Hiatus hernia. Patient Information

James Paget University Hospitals. NHS Foundation Trust. Hiatus hernia. Patient Information James Paget University Hospitals NHS Foundation Trust Hiatus hernia Patient Information What is a hiatus hernia? A hiatus hernia can cause highly irritating stomach contents, such as acid, to move up into

More information

SUMMARY OF PRODUCT CHARACTERISTICS. One chewable tablet contains 1250 mg calcium carbonate (equivalent to 500 mg calcium).

SUMMARY OF PRODUCT CHARACTERISTICS. One chewable tablet contains 1250 mg calcium carbonate (equivalent to 500 mg calcium). SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT [XXX] 500 mg chewable tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One chewable tablet contains 1250 mg calcium carbonate (equivalent

More information

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000 Package leaflet: Information for the user Omnilax 10 g powder for oral solution, sachet Macrogol 4000 Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides Package leaflet: Information for the user SenEase 7.5 mg tablets Sennosides Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep

More information

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Package leaflet: Information for the patient Megalac Hydrotalcite Chewable Tablets 500 mg Active substance: hydrotalcite Read all of this leaflet carefully before you start taking this medicine because

More information

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution Read all of this leaflet carefully before you give this medicine to your child because it contains important

More information

-Mohammad Ashraf. -Anas Raed. -Alia Shatnawi. 1 P a g e

-Mohammad Ashraf. -Anas Raed. -Alia Shatnawi. 1 P a g e -1 -Mohammad Ashraf -Anas Raed -Alia Shatnawi 1 P a g e Dr. Alia started the lecture by talking about subjects we are going to cover through this course; you can refer to the record if you are interested.

More information

NEXIUM INTRAVENOUS esomeprazole sodium

NEXIUM INTRAVENOUS esomeprazole sodium NEXIUM INTRAVENOUS esomeprazole sodium Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about NEXIUM Intravenous (IV). It does not contain

More information

* Adults. NSAID associated peptic ulceration: - Acute treatment: 150 mg twice daily for 8 to 12 weeks, or 300mg nocte.

* Adults. NSAID associated peptic ulceration: - Acute treatment: 150 mg twice daily for 8 to 12 weeks, or 300mg nocte. Trade Name Aciloc 75 mg & 300 mg Film-coated tablets Generic Name Ranitidine Composition Each Aciloc 300 mg film-coated tablet contains: - Active ingredient: Ranitidine hydrochloride 336 mg equivalent

More information

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE Pr SANDOZ PANTOPRAZOLE Pantoprazole Delayed-Release Tablets 20 mg and 40 mg Pantoprazole (as pantoprazole

More information

CONSUMER MEDICINE INFORMATION

CONSUMER MEDICINE INFORMATION CONSUMER MEDICINE INFORMATION HEALTH pantoprazole (as sodium sesquihydrate) 20 & 40 mg enteric coated tablets What is in this leaflet This leaflet answers some common questions about It does not contain

More information

Dulcolax Tablets and Dulcolax Suppositories Bisacodyl

Dulcolax Tablets and Dulcolax Suppositories Bisacodyl Consumer Medicine Information Tablets and Suppositories Bisacodyl What is in this leaflet 1. What is used for 2. Before you use a) When you must not use b) Before you start to use c) Pregnancy d) Breastfeeding

More information

Package leaflet: Information for the user. PARIET 10 mg and 20 mg gastro-resistant tablets Rabeprazole sodium

Package leaflet: Information for the user. PARIET 10 mg and 20 mg gastro-resistant tablets Rabeprazole sodium Package leaflet: Information for the user PARIET 10 mg and 20 mg gastro-resistant tablets Rabeprazole sodium Read all of this leaflet carefully before you start taking this medicine because it contains

More information

Objectives Brand name Generic name Primary indication, drug classes Dosage forms Patient counseling information Important side effects and contraindic

Objectives Brand name Generic name Primary indication, drug classes Dosage forms Patient counseling information Important side effects and contraindic laxatives Hawler medical university Collage of pharmacy/ fourth stage /pharmacy practice Sham A. Talat Shareef (B.Sc. Msc. clinical pharmacy) 2017-2018 Sham_talat@yahoo.com Head of Department Of Clinical

More information

FOSAMAX (Alendronic acid as alendronate sodium trihydrate)

FOSAMAX (Alendronic acid as alendronate sodium trihydrate) CSP - UK/H/PSUR/0070 - March 2012 EUROPEAN UNION CORE SAFETY PROFILE FOSAMAX (Alendronic acid as alendronate sodium trihydrate) 4.2 Posology and method of administration The recommended dosage is one 70

More information

Management of Dyspepsia

Management of Dyspepsia MPharm Programme Management of Dyspepsia Slide 1 of 28 Learning Objectives Understand the principles and wider implications underpinning evidence based therapeutics in the key clinical specialities Objectively

More information

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. Pantoprazole Magnesium Enteric-Coated Tablets

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. Pantoprazole Magnesium Enteric-Coated Tablets PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE Pr PANTOPRAZOLE T Pantoprazole Magnesium Enteric-Coated Tablets Read this carefully before you start taking

More information

PRODUCT INFORMATION UROCIT -K. Wax matrix tablets

PRODUCT INFORMATION UROCIT -K. Wax matrix tablets PRODUCT INFORMATION UROCIT -K Wax matrix tablets NAME OF DRUG Potassium Citrate CAS number- 6100-05-6 The empirical formula of potassium citrate is K 3 C 6 H 5 0 7.H 2 O, and its structural formula is:

More information

The Aging Digestive System

The Aging Digestive System The Aging Digestive System shows significant senescence in old age: less saliva food less flavorful, harder swallowing ~half of those over 65 yrs wear dentures gastric mucosa secretes less acid reduces

More information

Public Assessment Report. Mutual Recognition Procedure

Public Assessment Report. Mutual Recognition Procedure Public Assessment Report Mutual Recognition Procedure RENNIE DUAL ACTION TABLETS ALGINIC ACID CALCIUM CARBONATE MAGNESIUM CARBONATE HEAVY UK/H/1600/001/MR PL 00010/0514 Applicant: Bayer PLC 1 LAY SUMMARY

More information

Silent reflux (also known as LPR or EOR)

Silent reflux (also known as LPR or EOR) ENT - Information for patients Silent reflux (also known as LPR or EOR) Introduction This leaflet explains what your condition is, why it happens, what the symptoms are and how it can be managed. If there

More information

Package leaflet: Information for the user. Nicovel Frukt 4 mg medicated chewing-gum. nicotine

Package leaflet: Information for the user. Nicovel Frukt 4 mg medicated chewing-gum. nicotine Package leaflet: Information for the user Nicovel Frukt 2 mg medicated chewing-gum Nicovel Frukt 4 mg medicated chewing-gum nicotine Read all of this leaflet carefully before you start using this medicine

More information

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets RANITIDINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information

More information

Report generated from MPH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number.

Report generated from MPH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number. Report generated from MPH provided by Complete (www.pharmpress.com). Accessed 15 01 2016 Title Status Section TA Number TA Link Alu-Cap simeticone->aluminium- and magnesium-containing antacids->aluminium

More information

Pantoprazole (as sodium sesquihydrate) enteric coated tablets

Pantoprazole (as sodium sesquihydrate) enteric coated tablets SOZOL Consumer Medicine Information Pantoprazole (as sodium sesquihydrate) enteric coated tablets What is in this leaflet? This leaflet answers some common questions about SOZOL. It does not contain all

More information

Patient information. Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4

Patient information. Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4 Patient information Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4 You have been diagnosed with laryngopharyngeal reflux (LPR), otherwise known as extra-oesophageal reflux

More information

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate) PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate) Pfizer Logo Read all of this leaflet carefully before you start taking this

More information

[Al(OH) 3. ] x [H 2. O]y

[Al(OH) 3. ] x [H 2. O]y CARAFATE Tablets (sucralfate) DESCRIPTIN CARAFATE Tablets contain sucralfate and sucralfate is an α-d-glucopyranoside, β-dfructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex. R [Al(H) 3 ] x

More information

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium) Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet

More information

PATIENT INFORMATION LEAFLET. Nu-Seals 75 aspirin (acetylsalicylic acid)

PATIENT INFORMATION LEAFLET. Nu-Seals 75 aspirin (acetylsalicylic acid) PATIENT INFORMATION LEAFLET Nu-Seals 75 aspirin (acetylsalicylic acid) Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may need to read it again. If you

More information

Osteoporosis Care Sheet

Osteoporosis Care Sheet Osteoporosis Care Sheet Serial no Keynote for Osteoporosis Care Not to emphasize side effect too much. No need to explain too many things at the first counseling. Support patient's self care! 1) Diagnosis

More information

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1 PACKAGE LEAFLET DIASTABOL 50 MG TABLETS 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Diastabol 50 mg tablets miglitol Read all of this leaflet carefully before you start taking this medicine. - Keep this

More information

What pantoprazole is used for

What pantoprazole is used for CONSUMER MEDICINE INFORMATION sesquihydrate) 20 & 40 mg enteric coated tablets What is in this leaflet This leaflet answers some common questions about It does not contain all the available information.

More information

Alginates Extended Abstract

Alginates Extended Abstract Alginates Extended Abstract III) Clinical practice guidelines: DeVault KR, Castell DO; American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux

More information

Management of dyspepsia and of Helicobacter pylori infection

Management of dyspepsia and of Helicobacter pylori infection Management of dyspepsia and of Helicobacter pylori infection The University of Nottingham John Atherton Wolfson Digestive Diseases Centre University of Nottingham, UK Community management of dyspepsia

More information

Gastro-oesophageal reflux during pregnancy. Nigel Trudgill

Gastro-oesophageal reflux during pregnancy. Nigel Trudgill Gastro-oesophageal reflux during pregnancy Nigel Trudgill Summary How common? Which pregnancies? Why? Are there complications? How do we treat reflux during pregnancy? How common is reflux during 607 ante-natal

More information

Dulcolax 5 mg, film-coated tablets

Dulcolax 5 mg, film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Dulcolax 5 mg, film-coated tablets BISACODYL This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which

More information

Peptic ulcer disease Disorders of the esophagus

Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Disorders of the esophagus Peptic ulcer disease Burning epigastric pain Exacerbated by fasting Improved with meals Ulcer: disruption of mucosal integrity >5 mm in size, with depth

More information

Homely Remedies Protocol Version 4.0 For Care Homes with and without nursing

Homely Remedies Protocol Version 4.0 For Care Homes with and without nursing Name of Care Home: Signature of Care Home Manager: Date implemented: Definition: Homely Remedies Protocol Version 4.0 For Care Homes with and without nursing A homely remedy is a product that can be purchased,

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER 1 ethambutol hydrochloride Read all of this leaflet carefully before your child starts taking this medicine

More information

Section 1 Introduction to Swisse Training Module

Section 1 Introduction to Swisse Training Module Section 1 Introduction to Swisse Training Module 1 Introduction to Swisse Product Training The underlying goal of every recommendation is to create value for customers by understanding their problems,

More information

Homely Remedies Guidance

Homely Remedies Guidance Homely Remedies Guidance Guidance from the Royal Pharmaceutical Society of Great Britain (RPSGB) in The Handling of Medicines in Social Care, states that care homes are able to purchase medicines for use

More information